Advanced search
Publication Cover
Expert Review of Gastroenterology & Hepatology Volume 1, 2007 - Issue 1
Submit an article Journal homepage
35
Views
5
CrossRef citations to date
0
Altmetric
Review

Pharmacoeconomic considerations for inflammatory bowel disease in the era of biological therapies

Tojo Thomas Resident in Internal Medicine, University of Chicago Hospitals, 5841 S. Maryland Avenue MC 4076, Chicago, IL 60637, USA. [email protected]
&
Russell D Cohen Associate Professor of Medicine, University of Chicago Medical Center, 5841 S. Maryland Avenue MC 4076, Chicago, IL 60637, USA. [email protected]
Pages 101-112 | Published online: 10 Jan 2014

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Paweł Kawalec & Krzysztof Piotr Malinowski. (2015) Indirect health costs in ulcerative colitis and Crohn’s disease: a systematic review and meta-analysis. Expert Review of Pharmacoeconomics & Outcomes Research 15:2, pages 253-266.
Read now

Articles from other publishers (4)

Derek H. Tang, Amanda R. Harrington, Jeannie K. Lee, Mark Lin & Edward P. Armstrong. (2013) A Systematic Review of Economic Studies on Biological Agents Used to Treat Crohn’s Disease. Inflammatory Bowel Diseases 19:12, pages 2673-2694.
Crossref
K. T. Park & Dorsey Bass. (2011) Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States. Inflammatory Bowel Diseases 17:7, pages 1603-1609.
Crossref
Nanda Venu & Russell D. Cohen. 2011. Inflammatory Bowel Disease. Inflammatory Bowel Disease 295 313 .
Yang Sun, Tian-Tian Cai, Yan Shen, Xiao-Bin Zhou, Ting Chen & Qiang Xu. (2009) Si-Ni-San, a traditional Chinese prescription, and its active ingredient glycyrrhizin ameliorate experimental colitis through regulating cytokine balance. International Immunopharmacology 9:12, pages 1437-1443.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.